Y, Q., Z, W., H, Z., M, K., R, D., & J, Z. (2017). Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155. Dove Medical Press.
Cita Chicago Style (17a ed.)Y, Qu, Wang Z, Zhou H, Kang M, Dong R, y Zhao J. Oligosaccharide Nanomedicine of Alginate Sodium Improves Therapeutic Results of Posterior Lumbar Interbody Fusion with Cages for Degenerative Lumbar Disease in Osteoporosis Patients by Downregulating Serum MiR-155. Dove Medical Press, 2017.
Cita MLA (8a ed.)Y, Qu, et al. Oligosaccharide Nanomedicine of Alginate Sodium Improves Therapeutic Results of Posterior Lumbar Interbody Fusion with Cages for Degenerative Lumbar Disease in Osteoporosis Patients by Downregulating Serum MiR-155. Dove Medical Press, 2017.